Depressive symptoms in patients with subclinical hypothyroidism-the effect of treatment with levothyroxine: A double-blind randomized clinical trial

Endocrine Research

Volumn 40, Issue 3, 2015, Pages 121-126

  Najafi, Laily ^a   Malek, Mojtaba ^a   Hadian, Ali ^a   Ebrahim Valojerdi, Ameneh ^a   Khamseh, Mohammad E ^a   Aghili, Rokhsareh ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Affective subscale; Beck Depression Inventory; Depression; Neuropsychiatric alterations; Somatic subscale; Thyroid dysfunction

Indexed keywords

LEVOTHYROXINE; PLACEBO; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRY SKIN; FATIGUE; FEMALE; HOARSENESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENSTRUAL IRREGULARITY; MUSCLE CRAMP; NAIL DISEASE; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCLINICAL HYPOTHYROIDISM; THERAPY EFFECT; THYROTROPIN BLOOD LEVEL; WEIGHT GAIN; COMPLICATION; HYPOTHYROIDISM; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; THYROXINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84936932310     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2014.896924     Document Type: Article

References (76)

1. Swierzewski SJ. Incidence & prevalence of depression. 2001 Feb 03. Available at: http://www.healthcommunities.com/depression/incidence-prevalence.shtml [last accessed 3 Mar 2011].
2. Almeida OP, Alfonso H, Flicker L, et al. Thyroid hormones and depression: the health in men study. Am J Geriatr Psychiatry 2011; 19:763-70.
3. Almeida OP, Calver J, Jamrozik K, et al. Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry 2009;17:889-98.
4. Almeida OP, Burton EJ, Ferrier N, et al. Depression with late onset is associated with right frontal lobe atrophy. Psychol Med 2003;33: 675-81.
5. Almeida OP, McCaul K, Hankey GJ, et al. Homocysteine and depression in later life. Arch Gen Psychiatry 2008;65:1286-94.
6. Almeida OP, Flicker L, Norman P, et al. Association of cardiovascular risk factors and disease with depression in later life. Am J Geriatr Psychiatry 2007;15:506-13.
7. Djernes JK. Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand 2006;113:372-87.
8. Draper B, Pfaff JJ, Pirkis J, et al. Long-term effects of childhood abuse on the quality of life and health of older people: results from the depression and early prevention of suicide in general practice project. J Am Geriatr Soc 2008;56:262-71.
9. Cassano P, Fava M. Depression and public health: an overview. J Psychosom Res 2002;53:849-57.
10. Cleare AJ, McGregor A, OKeane V. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clin Endocrinol (Oxf) 1995;43:713-19.
11. Farmer A, Korszun A, Owen MJ, et al. Medical disorders in people with recurrent depression. Br J Psychiatry 2008;192:351-5.
12. Gold MS, Pottash AL, Extein I. Hypothyroidism and depression. Evidence from complete thyroid function evaluation. JAMA 1981; 245:1919-22.
13. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008;29:76-131.
14. Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004;292:2591-9.
15. Surks MI, Ocampo E. Subclinical thyroid disease. Am J Med 1996; 100:217-23.
16. Osterweil D, Syndulko K, Cohen SN, et al. Cognitive function in non-demented older adults with hypo - thyroidism. J Am Geriatr Soc 1992;40:325-35.
17. Matuszek B, Strawa-Zakosćielna K, Pyzik A, et al. The analysis of the clinical picture of hypothyroidism in menopausal women. Przegl Menopauz 2010;6:390-6.
18. Aghili R, Khamseh ME, Malek M, et al. Changes of subtests of Wechsler Memory Scale and cognitive function in subjects with subclinical hypothyroidism following treatment with levothyroxine. Arch Med Sci 2012;8:1096-101.
19. Haggerty Jr JJ, Stern RA, Mason GA, et al. Subclinical hypothyroidism: a modifiable risk factor for depression. Am J Psychiatry 1993;150:508-10.
20. Placidi GP, Boldrini M, Patronelli A, et al. Prevalence of psychiatric disorders in thyroid disease patient. Neuropsychology 1998;38:222-5.
21. Correia N, Mullally S, Cooke G, et al. Evidence for a specific defect in hippocampal memory in overt and subclinical hypothyroidism. J Clin Endocrinol Metab 2009;94:3789-97.
22. Geffken GR, Ward HE, Staab JP, et al. Psychiatric morbidity in endocrine disorders. Psychiatr Clin North Am 1998;21:473-89.
23. Gur E, Lerer B, Newman ME. Chronic chlomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: relationship to serotonin autoreceptor activity. J Pharmacol Exp Ther 1999;288:81-7.
24. Cooper DS. Clinical practice: subclinical hypothyroidism. N Engl J Med 2001;345:260-5.
25. Toft AD. Clinical practice: subclinical hyperthyroidism. N Engl J Med 2001;345:512-16.
26. Ayala A, Danese MD, Ladenson PW. When to treat mild hypothyroidism. Endocrinol Metab Clin North Am 2000;29: 399-415.
27. Col NF, Surks MI, Daniels GH. Subclinical thyroid disease: clinical applications. JAMA 2004;291:239-43.
28. Miller KJ, Parsons TD, Whybrow PC, et al. Memory improvement with treatment of hypothyroidism. Int J Neurosci 2006;116: 895-906.
29. Samuels MH, Schuff KG, Carlson NE, et al. Health status, psychological symptoms, mood, and cognition in Lthyroxinetreated hypothyroid subjects. Thyroid 2007;17:249-58.
30. Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol 2007;32:49-65.
31. Helfand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004;140:128-41.
32. Literature available on Psychiatric Assessment Instruments translated in non-English languages: TBDI Section. Victorian Transcultural Psychiatry Unit. December 2005. Archived from the original on 19 July 2008. Retrieved 2009-02-24.
33. Beck AT, Ward C, Mendelson M. Beck Depression Inventory (BDI). Arch Gen Psychiatry 1961;4:561-71.
34. Beck AT, Steer RA, Ball R, et al. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996;67:588-97.
35. Steer RA, Ball R, Ranieri WF, et al. Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. J Clin Psychol 1999;55:117-28.
36. Storch EA, Roberti JW, Roth DA. Factor structure, concurrent validity, and internal consistency of the Beck Depression Inventory- Second Edition in a sample of college students. Depress Anxiety 2004;19:187-9.
37. Sharlin DS, Gilbert ME, Taylor M, et al. The nature of the compensatory response to low thyroid hormone in the developing brain. J Neuroendocrinol 2010;22:153-65.
38. Burmeister LA, Ganguli M, Dodge HH, et al. Hypothyroidism and cognition: preliminary evidence for a specific defect in memory. Thyroid 2001;11:1177-85.
39. Smith JW, Evans AT, Costall B, et al. Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev 2002;26:45-60.
40. Hoogendoorn EH, Heijer MD, Dijk AJ, et al. Sub-clinical hyperthyroidism: to treat or not to treat? Postgrad Med J 2004; 80:394-8.
41. Pale JV, Franklyn JA, Cross KW, et al. Prevalence and follow up of abnormal thyrotophin (TSH) concentration in the elderly in the United Kingdom. Clin Endocrinol 1991;34:77-83.
42. Kabadi UM. Subclinical hypothyroidism. Natural course of syndrome during a prolonged follow-up study. Arch Intern Med 1993;153:957-61.
43. Davis JD, Stern RA, Flashman LA. Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly. Curr Psychiatry Rep 2003;5:384-90.
44. Villar HCCE, Saconato H, Valente O, et al. Thyroid hormone replacement for subclinical hypothyroidism. Coch Data Syst Rev 2007;3:CD003419.
45. Vaisman M. Clínica médica, doenças da tireoide. Sao Paulo, SP: Atheneu; 2003.
46. Gulseren S, Gulseren L, Hekimsoy Z, et al. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res 2006;37:133-9.
47. Kramer CK, von Mühlen D, Kritz-Silverstein D, et al. The association of thyroid stimulating hormone levels with cognitive function and depressed mood: the Rancho Bernardo study. J Nutr Health Aging 2009;13:317-21.
48. Saravanan P, Chau WR, Roberts N. Psychological well being in patients on adequate doses of L-thyroxine: results of a large controlled community-based questionnaire study. Clin Endocrinol 2003;57:577-85.
49. Larisch R, Kley K, Nikolaus S, et al. Depression and anxiety in different thyroid function states. Horm Metab Res 2004;36:650-3.
50. Samuels MH, Schuff KG, Carlson NE, et al. Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis. J Clin Endocrinol Metab 2008;93:1730-6.
51. Lasser RA, Baldessarini RJ. Thyroid hormones in depressive disorders: a reappraisal of clinical utility. Harv Rev Psychiatry 1997;4:291-305.
52. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. J Am Med Assoc 2004;291:228-38.
53. Simonsick EM, Newman AB, Ferrucci L, et al. Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med 2009;169:2011-17.
54. Schlote B, Nowotny B, Schaaf L, et al. Subclinical hyperthyroidism: physical and mental state of patients. European Arch Psychiatry Clin Neurosci 1992;241:357-64.
55. Razvi S, Weaver JU, Vanderpump MP, et al. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab 2010;95:1734-40.
56. Reuters VS, Teixeira PF, Vigario PS, et al. Functional capacity and muscular abnormalities in subclinical hypothyroidism. Am J Med Sci 2009;338:259-63.
57. Portella RB, Silva JL, Wagman MB, et al. Exercise performance in young and middle-Aged female patients with subclinical hyperthyroidism. Thyroid 2006;16:731-5.
58. Brennan MD, Powell C, Kaufman KR, et al. The impact of overt and subclinical hyperthyroidism on skeletal muscle. Thyroid 2006; 16:375-80.
59. Ceresini G, Lauretani F, Maggio M, et al. Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J Am Geriatr Soc 2009;57:89-93.
60. Begin ME, Langlois MF, Lorrain D, et al. Thyroid function and cognition during aging. Curr Gerontol Geriatr Res 2008;2008: 474868.
61. Park YJ, Lee EJ, Lee YJ, et al. Subclinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life (QoL) in elderly subjects. Arch Gerontol Geriatr 2010;50:e68-73.
62. Parle J, Roberts L, Wilson S, et al. A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. J Clin Endocrinol Metab 2010;95:3623-32.
63. Chueire VB, Romaldini JH, Ward LS. Subclinical hypothyroidism increases the risk for depression in the elderly. Arch Gerontol Geriatr 2007;44:21-8.
64. Almeida C, Brasil MA, Costa AJ, et al. Subclinical hypothyroidism: psychiatric disorders and symptoms. Rev Bras Psiquiatr 2007;29: 157-9.
65. Demartini B, Masu A, Scarone S, et al. Prevalence of depression in patients affected by subclinical hypothyroidism. Panminerva Med 2010;52:277-82.
66. Engum A, Bjoro T, Mykletun A, et al. An association between depression, anxiety and thyroid function-A clinical fact or an artefact? Acta Psychiatr Scand 2002;106:27-34.
67. de Jongh RT, Lips P, van Schoor NM, et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol 2011;165: 545-54.
68. Jorde R, Waterloo K, Storhaug H, et al. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab 2006;91:145-53.
69. Almeida-Filho N, Mari Jde J, Coutinho E, et al. Brazilian multicentric study of psychiatric morbidity. Methodological features and prevalence estimates. Br J Psychiatry 1997;171: 524-9.
70. Baumgartner A. Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research. Int J Neuropsychopharmacol 2000;3:149-65.
71. Aronson R, Offman HJ, Joffe RT, et al. Triiodothyronine augmentation in the treatment of refractory depression. A meta-Analysis. Arch Gen Psychiatry 1996;53:842-8.
72. Nierenberg AA, Fava M, Trivedi MH, et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STARD report. Am J Psychiatry 2006; 163:1519-30.
73. Cooper-Kazaz R, Apter JT, Cohen R, et al. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2007; 64:679-88.
74. Prange Jr AJ, Wilson IC, Rabon AM, et al. Enhancement of imipramine antidepressant activity by thyroid hormone. Am J Psychiatry 1969;126:457-69.
75. Cleare AJ, McGregor A, Chambers SM, et al. Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothyroidism. Neuroendocrinology 1996;64:65-9.
76. van Harten AC, Leue C, Verhey FR. Should depressive symptoms in patients with subclinical hypothyroidism be treated with thyroid hormone? Tijdschr Psychiatr 2008;50:539-43.